Figma Acquires AI Agent Platform Bud From Y Combinator For Team Integration

Figma has acquired the team behind Bud (formerly Orchids), a Y Combinator-backed startup that evolved from a vibe-coding platform into an AI agent platform capable of browsing the web, writing code, and automating tasks. The acquisition reflects Figma’s broader push to expand beyond design and bring AI-powered coding, prototyping, and app-building capabilities closer to its platform. Commenting on the deal, Bud CEO Kevin Lu said that Figma is a natural home for this new era of AI-driven work. As part of the acquisition, Bud and Orchids will shut down by July 18, with users required to migrate their projects before then. Notably, the details provided do not mention any recent funding raise for Bud. #VentureCapital #Figma #Buds #TradedVC

More Deals

View All

Mercor In Talks To Raise $20 Billion Following Deeptune Acquisition And Revenue GrowthMercor, an AI training startup, is reportedly in early discussions to raise a new funding round at a $20 billion valuation. The potential valuation would double the company’s $10 billion valuation from October 2025, when it raised a $350 million Series C round. Founder and CEO Brendan Foody recently stated that Mercor’s annualized revenue run rate has surpassed $2 billion, representing 100% growth in just four months. The company also announced the acquisition of Deeptune, an AI agent training firm, with the entire Deeptune team joining Mercor. The strong revenue growth, acquisition activity, and prospective funding round suggest Mercor is continuing to expand despite challenges earlier this year, including a data breach and legal disputes involving contract workers. FOUNDER: Brendan Foody AMOUNT: $20,000,000,000 HQ: San Francisco, California #VentureCapital #Mercor #BrendanFoody #TradedVC

Klinic Secures $24 Million In Seed And Series A Funding From Proofpoint Capital And I2BF Global VenturesKlinic, an AI-enabled specialty care access platform, has raised $24 million in combined seed and Series A funding to expand its provider network, enhance its AI-powered platform, and grow its life sciences partnerships. The round was co-led by Proofpoint Capital and I2BF Global Ventures, with representatives from both firms joining Klinic’s board. Founded and led by CEO Avish Bhama, Klinic helps patients navigate the often complex specialty care journey by using artificial intelligence and workflow automation to streamline provider matching, insurance verification, prior authorizations, patient communications, and pharmacy coordination. The company has already supported more than 150,000 patients and aims to make specialty care access faster, more connected, and more affordable. FOUNDER: Avish Bhama INVESTORS: Proofpoint Capital & I2BF Global Ventures ROUND: Seed & Series A AMOUNT: $24,000,000 HQ: Dallas, Texas #VentureCapital #Klinic #AvishBhama #TradedVC